Pharmaceutical

Bristol Myers Squibb’s Breyanzi receives EC approval to...

Breyanzi’s approval is based on the data obtained from the Phase III TRANSFORM t...

Idorsia’s Quviviq receives marketing authorisation from...

The regulatory decision is supported by data from Phase III clinical trials and ...

STAT+: CAR-T research is flourishing but is hampered by...

A gathering of experts in CAR-T cancer therapy at #STAT breakthrough express opt...

An MRI helmet out of ‘Back to the Future’ wins STAT Sum...

At the #STATBreakthrough Summit, researchers made scientific pitches as ambitiou...

Don’t ignore potential microbial causes of Alzheimer’s ...

Studies in human brain tissue, neural stem cells, and mice have linked the herpe...

STAT+: Vinod Khosla predicts AI doctors could be here s...

“There’s very few physicians who understand what technology can do, and definite...

STAT+: What the Covid-19 pandemic can teach us about dr...

“Thirty years after the HIV epidemic, why is there still a time lag of years to ...

After early-stage breast cancer, interrupting endocrine...

After early-stage breast cancer, women can pause taking endocrine therapy to bec...

For Eli Lilly’s head scientist, Alzheimer’s results cap...

"Probably any words I use to describe my emotions at seeing this data will under...

Now 18, the first child to ever receive CAR-T cancer th...

At six years old, Emily Whitehead became the first child to receive CAR-T cancer...

Oft-prescribed beta blockers may not be wise for many h...

Two new studies, while both observational, suggest that the longstanding practic...

DEA will delay telemedicine restrictions for buprenorph...

After receiving 38,000 public comments, the DEA announces a delay in new rules t...

FDA approves first RSV vaccine, a long-sought scientifi...

The FDA has approved the first-ever vaccine for respiratory syncytial virus, or ...

STAT+: Pharmalittle: Lilly’s Alzheimer’s drug slowed co...

A new Eli Lilly Alzheimer's treatment slowed the rate of cognitive and functiona...

STAT+: Immunogen ovarian cancer drug shown to extend pa...

A drug approved in November as the first new treatment for advanced ovarian canc...

STAT+: In early glimpse at data, Akili’s video game sho...

An early glimpse at Akili's new data in adults offers welcome news for a company...